Massachusetts General Hospital and iConquer MS surveyed more than 1,000 people living with MS about the impact of the COVID-19 pandemic on their daily lives. We're among the first to hear the survey results from investigator Dr. Farrah Mateen and Hollie Schmidt.
MS research is about to take a quantum leap forward. We're talking about how the MULTI-ACT patient engagement roadmap will change the face of MS research and involve people affected by MS in ways that they've never been involved in research before.
And we'll share new data from an ongoing clinical trial that's evaluating a cutting-edge cell therapy designed to eliminate B-cells carrying the Epstein-Barr virus. (Many experts believe that eliminating the Epstein-Barr virus Barr virus might eliminate most multiple sclerosis.)
We have a lot to talk about! Are you ready for RealTalk MS??!
The International Progressive MS Alliance is partnering with MULTI-ACT — and why that's a major step forward in MS research 2:26
New Data About ATA 188 Cell Therapy Clinical Trial Shared at the European Academy of Neurology Virtual Meeting 5:47
Dr. Farrah Mateen & Holly Schmidt Share Results from the Massachusetts General Hospital/iConquer MS COVID-19 Survey 10:08
My Interview with Dr. Amy Sullivan 30:21
Share this episode 41:27
Please Support the National MS Society COVID-19 Response Fund 41:50
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/144
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
RealTalk MS Episode 144
Hosted By: Jon Strum
Guests: Dr. Amy Sullivan, Dr. Farrah Mateen, Hollie Schmidt
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, Coronavirus, COVID19, iConquerMS, RealTalkMS